Integer (NYSE:ITGR) Reaches New 12-Month High Following Analyst Upgrade

Integer Holdings Co. (NYSE:ITGR) reached a new 52-week high during trading on Monday after Truist Financial raised their price target on the stock from $145.00 to $150.00. Truist Financial currently has a buy rating on the stock. Integer traded as high as $132.00 and last traded at $131.87, with a volume of 118980 shares trading hands. The stock had previously closed at $129.24.

Several other research firms have also issued reports on ITGR. Bank of America increased their target price on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Citigroup increased their target price on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Benchmark reissued a “buy” rating and issued a $130.00 target price on shares of Integer in a report on Wednesday, October 2nd. Finally, Oppenheimer initiated coverage on shares of Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price for the company. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $138.00.

Insider Buying and Selling at Integer

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares of the company’s stock, valued at $272,824.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after acquiring an additional 23,382 shares during the last quarter. Earnest Partners LLC lifted its position in Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after buying an additional 37,340 shares during the last quarter. Congress Asset Management Co. MA lifted its position in Integer by 7.5% in the first quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock worth $52,886,000 after buying an additional 31,736 shares during the last quarter. Driehaus Capital Management LLC lifted its position in Integer by 62.5% in the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after buying an additional 135,750 shares during the last quarter. Finally, Tributary Capital Management LLC lifted its position in Integer by 0.3% in the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock worth $33,168,000 after buying an additional 772 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Stock Performance

The company has a market capitalization of $4.44 billion, a P/E ratio of 45.82, a P/E/G ratio of 1.86 and a beta of 1.08. The business has a 50-day moving average of $125.46 and a 200-day moving average of $120.24. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. The company had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. Integer’s revenue was up 9.0% on a year-over-year basis. During the same period last year, the company earned $1.14 earnings per share. On average, sell-side analysts anticipate that Integer Holdings Co. will post 5.3 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.